Top Markets
#1 DogBull DogBull +106.14%
#2 Siacoin Siacoin +53.78%
#3 ADO Protocol ADO Protocol +50.84%
#4 The Bitcoin Bull The Bitcoin Bull +43.39%
#5 龙虾 (Lobster) 龙虾 (Lobster) +36.69%
#6 MarsCoin MarsCoin +35.12%
#7 Glidr Glidr +25.30%
#8 UnifAI Network UnifAI Network +19.90%
#9 Ontology Gas Ontology Gas +19.05%
#10 Falcon Finance Falcon Finance +16.87%
Coin of the day
DogBull DogBull
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Clover Biopharmaceuticals, Ltd. Clover Biopharmaceuticals, Ltd.

Clover Biopharmaceuticals, Ltd.

2197
Rang în acțiuni #15712
Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on... Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on discovering, developing, and commercializing innovative vaccines and biological therapies. Their efforts target infectious diseases, various cancers, and autoimmune conditions. The company's pipeline features several key candidates: SCB-2019 (CpG 1018/Alum): A COVID-19 vaccine candidate currently advancing through Phase II/III clinical trials. SCB-313: A trimeric fusion protein aimed at treating severe intracavitary malignancies, including malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis, addressing a significant global medical need. SCB-808: Undergoing pivotal Phase III clinical trials for the management of rheumatic disorders. SCB-420: An aflibercept biosimilar in preclinical development for ophthalmologic conditions like wet age-related macular degeneration. SCB-219: A novel TPOR agonist in preclinical stages for the treatment of chemotherapy-induced thrombocytopenia and immune thrombocytopenic purpura. Clover also holds a collaboration and supply agreement with Dynavax, which provides its CpG 1018 adjuvant for use in preclinical studies. The company was established in 2007 and is based in Shanghai, China.
Preț acțiune
$0.25841098
Capitalizare de piață
$335.38M
Schimbare (1 zi)
-2.42%
Schimbare (1 an)
73.70%
Țară
CN
Tranzacționează Clover Biopharmaceuticals, Ltd. (2197)

Categorie

Healthcare
Istoric dividende pentru Clover Biopharmaceuticals, Ltd. (2197)
Clover Biopharmaceuticals, Ltd. (simbol acțiune: 2197) a efectuat un total de 0 plăți de dividende.
Suma tuturor dividendelor (ajustată pentru split-uri de acțiuni) este: 0.00
Randamentul dividendului (TTM): 0
Plăți de dividende pentru Clover Biopharmaceuticals, Ltd. (2197) din 2026 până în 2026
Plăți anuale de dividende
An Dividend (ajustat pentru split de acțiuni) Schimbă
Nu sunt suficiente date pentru perioada selectată.
Lista tuturor plăților de dividende
An Dividend Schimbă
Nu sunt suficiente date pentru perioada selectată.
Dividende ale companiilor similare sau concurente
Companie Număr de plăți de dividende Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH